Elan is a neuroscience-based biotechnology company headquartered in Dublin, Ireland with research and development, manufacturing and marketing facilities in Ireland and the United States. The company’s bioneurology work includes research, development and commercial activities for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, and autoimmune diseases, including multiple sclerosis. See http://www.elan.com/.